1 Min Read
May 31 (Reuters) - Baytacare Pharmaceutical Co Ltd
* Appointment of Jiang Xiaobin as executive director was approved by shareholders and appointment took effect immediately Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.